Language:

Tucuvi Raises $20M Series A to Accelerate Adoption of Its AI Care Management Platform Across Healthcare Organizations

January 8, 2026
Europe

New York, January 8, 2026 – The round was led by Cathay Innovation and Kfund, through its early-growth fund Leadwind, with participation from existing investors Frontline Ventures, Seaya Ventures, and Shilling, to support go-to-market expansion and product development.

Tucuvi, a pioneer in Clinical Voice AI for care management, today announced it has raised $20 million in Series A funding to accelerate adoption of its AI Care Management platform across healthcare systems. The round was led by Cathay Innovation and Leadwind, with participation from existing investors Frontline Ventures, Seaya Ventures, and Shilling.

Healthcare systems are facing unprecedented strain from workforce shortages, rising patient demand, and growing operational complexity. Tucuvi was founded to address these challenges by delivering safe, auditable, and autonomous AI agents that expand care capacity while preserving clinical quality and trust

Unlike AI systems that observe and document care, Tucuvi is built to actively deliver care at scale. Tucuvi has developed an AI Care Management platform designed to automate and orchestrate high-volume care workflows end to end.

The platform is built around AI agents, including LOLA, a Voice AI agent that safely conducts patient phone conversations, executes clinical and care coordination workflows, and escalates to human teams when needed.

Today, Tucuvi supports more than 50 workflows, ranging from post-surgical follow-ups and transitions of care to chronic care management, pre-operative assessments, screenings, scheduling, or medication management.

Tucuviʼs Voice AI agents handle complex, real-world patient phone interactions, while the broader platform manages workflow logic, escalation, documentation, and integration into existing health system operations – enabling organizations to move from isolated automation to end-to-end, agentic care management.

 

“Healthcare is under immense pressure, and incremental tools are no longer enough,ˮ said Maria Gonzalez, CEO of Tucuvi. “The only way to continue delivering high-quality care at scale is with AI that healthcare organizations can truly trust – AI that is safe, auditable, and built for real clinical environments. Weʼre proud to already serve more than 60 healthcare organizations and to be expanding rapidly to meet growing demand.ˮ

 

Built for Trust, Safety, and Clinical Reality

Tucuvi has led the real-world deployment of Voice AI in healthcare and has set a high bar for responsible AI adoption. The company is the first AI platform to receive European regulatory approval as a Class IIb Software as a Medical Device (SaMD) for its Voice AI agent and patient management platform.

This regulatory milestone reflects Tucuviʼs focus on clinical safety, transparency, explainability, and auditability – capabilities increasingly required by health systems deploying autonomous AI at scale.

 

Demonstrated Clinical, Operational, and Financial Impact

Tucuviʼs platform has delivered consistent, measurable results across partner health systems, including:

  • Up to 80% automation of nursing follow-up workflows
  • Patient reach and engagement above 90% across high-complexity patient populations
  • Chronic care outcomes improvements, such as a 5.5% reduction in COPD readmissions

 

“Tucuvi platform transforms protocols and guidelines into actual, reliable and consistent AI workflows, enabling us to engage with all our patients and let our nursing team dedicate their expertise to cases that need high-value clinical judgment.

— Chief Medical Officer, Health System

Designed to be modular and adaptable, Tucuviʼs AI can be tailored to local workflows, regulatory requirements, and care models – enabling healthcare organizations to scale care management without scaling clinical workload or disrupting existing operations.

“What convinced us at Cathay Innovation is Tucuvi’s rare ability to combine clinical rigor, regulatory credibility, and real-world scalability in one platform,” said Jacky Abitbol, Managing Partner at Cathay Innovation. “Their approach enables healthcare organizations to deploy autonomous AI with confidence, unlocking meaningful capacity for care teams while maintaining the highest levels of safety and quality. We believe Tucuvi is breaking new ground for how AI can be responsibly embedded into healthcare operations.”

With this funding, Tucuvi will accelerate go-to-market efforts across Europe and the US, expand its agentic AI capabilities, and continue evolving its platform into a system of action and intelligence for care teams.

 

About Tucuvi

Tucuvi is a pioneer in Clinical Voice AI for Care Management, founded to help healthcare organizations deliver high-quality care at scale amid growing workforce shortages and operational complexity. Purpose-built for real clinical environments, Tucuviʼs platform enables healthcare organizations to move beyond documentation and automation toward active, end-to-end care delivery powered by AI agents.

Tucuviʼs AI Care Management platform orchestrates high-volume clinical and care coordination workflows, combining autonomous Voice AI agents with workflow logic, escalation, documentation, and integration into existing health system operations. Its Voice AI agent, LOLA, conducts patient phone conversations, executes clinically validated protocols, and escalates to human teams when needed, allowing care teams to focus on cases that require high-value clinical judgment.

Designed for trust, safety, and auditability, Tucuvi is the first AI platform to receive European regulatory approval as a Class IIb Software as a Medical Device (SaMD) for both its Voice AI agent and Care Management platform. Today, Tucuvi supports more than 50 care workflows across post-acute care, chronic disease management, screenings, scheduling and care transitions, serving healthcare organizations across Europe and the United States and setting the standard for responsible, scalable AI-powered care delivery.

 

About Cathay Innovation

Cathay Innovation is a multistage venture capital firm, affiliated to Cathay Capital, investing in founders building transformative businesses across Europe, North America, Asia, Latin America and Africa. Its platform connects founders with investors and its ecosystem of leading Fortune500 corporations to help startups scale and transform industries with consumer to enterprise and AI solutions in commerce, fintech, digital health and mobility / energy. Founded in Paris in 2015, Cathay Innovation now manages over €2.5B AUM with additional offices in San Francisco, Berlin, Madrid, Shanghai and Singapore and has invested in over 120 startups including Chime, Pinduoduo (NASDAQ: PDD), Glovo, Wallbox (NYSE: WBX), Owkin, Getaround, Ledger, ZenBusiness, Alma, Descartes Underwriting and more. To learn more, visit us at www.cathayinnovation.com.